News

Small improvement seen in teenager with vCJD

BMJ 2003; 327 doi: http://dx.doi.org/10.1136/bmj.327.7418.765-a (Published 02 October 2003) Cite this as: BMJ 2003;327:765
  1. Susan Mayor
  1. London

    Neurologists have expressed cautious optimism about small improvements and lack of toxicity in a UK teenager with variant Creutzfeldt-Jakob disease (vCJD) treated with an experimental drug, pentosan polysulphate.


    Embedded Image

    Don Simms (left) father of vCJD patient Jonathan Simms with the patient's GP, Dr Mark McClean, at the Stormont Hotel, Belfast

    Credit: PAUL FAITH/PA

    The patient, 19 year old Jonathan Simms …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe